TESAMORELIN Product Specifications:

Tesamorelin, a synthetic peptide, mimics growth hormone-releasing hormone (GHRH). Scientists engineer it with 44 amino acids, adding a trans-3-hexenoic acid group. Consequently, this modification boosts its stability. Moreover, its structure closely resembles natural GHRH. Thus, tesamorelin captivates researchers in peptide science.

The peptide binds strongly to GHRH receptors, showing high specificity. Furthermore, it resists rapid degradation in the body. As a result, scientists study its chemical resilience. Additionally, its production uses advanced peptide synthesis techniques. Hence, researchers probe its manufacturing process.

Tesamorelin’s development by Theratechnologies marked a key advance. Initially, scientists crafted it in the early 2000s for research purposes. Subsequently, its name derives from its unique chemical makeup. Moreover, it draws global interest in biochemical studies. Therefore, it fuels cutting-edge experiments.

In research, tesamorelin circulates effectively in experimental models. Furthermore, it maintains stability under physiological conditions. Consequently, scientists explore its pharmacokinetic behavior. Additionally, labs worldwide investigate its structural properties. Thus, tesamorelin drives progress in peptide research, sparking curiosity and encouraging deeper scientific inquiry.

• Appearance:Solid white powder in 3ml glass vial
• Chemical Formula:C223H370N72O69S
• PubChem CID:44147413
• CAS Number:901758-09-6
• Molecular Weight:5195.908 g/mol
• Storage:Store in a cool, dry place away from light, heat and moisture
• Synonyms:Growth Hormone Releasing Hormone Analogue, GHRH Analogue
• Sequence:Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
• Concentration:≥98%